|
|
Volumn 37, Issue 2, 2002, Pages 169-174
|
|
Positron emission tomography in thyroid cancer management
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAGNOSTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RADIOACTIVE IODINE;
RADIOPHARMACEUTICAL AGENT;
IODINE 131;
RECOMBINANT THYROTROPIN;
THYROGLOBULIN;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
HUMAN;
METASTASIS;
METHODOLOGY;
REVIEW;
SCINTISCANNING;
THYROID TUMOR;
ARTICLE;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC APPROACH ROUTE;
DIAGNOSTIC IMAGING;
DIAGNOSTIC VALUE;
DOSIMETRY;
FOLLOW UP;
HIGH RISK PATIENT;
HYPOTHYROIDISM;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTOR;
THYROID CANCER;
TREATMENT PLANNING;
FLUORODEOXYGLUCOSE F18;
HUMANS;
IODINE RADIOISOTOPES;
NEOPLASM METASTASIS;
RADIOPHARMACEUTICALS;
THYROID NEOPLASMS;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 0035996005
PISSN: 0037198X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0037-198X(02)80035-9 Document Type: Article |
|
Times cited : (68)
|
|
References (12)
|
